The clinical studies on weight loss outcomes with Ozempic and Metformin show: Ozempic : 10-15% body weight (clinical trial range) Metformi n: 2-5% body weight Combined : No fixed number, but may improve consistency of results Keep in mind that diet, physical activity, and treatment adherence are pivotal for outcomes
Central to this shift is the recognition that intestinal reparative therapy, defined by objective endpoints such as endoscopic and histologic healing, is strongly associated with improved long-term outcomes
Most clients experience no side effects, though some may notice minor swelling or redness at the injection site
Do not freeze: Freezing damages the formulation and should be avoided
A glycine-based compound would be a better fit
Some foods that make this list are white bread, roasted nuts, potatoes, eggplant, beets, rhubarb, pasta, beef, and sweetbreads